Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company BerGenBio A/S
DescriptionMurine, high affinity Axl function-blocking mAb
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationPancreatic cancer
Indication DetailsTreat pancreatic ductal adenocarcinoma (PDAC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today